Cocrystal Pharma

COCP • NASDAQ • Stock Fundamentals

Cocrystal Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sam Lee, with a market cap of $15.9M.

Market Cap$15.9M

Employees12.0

CEOSam Lee

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 21, 2026 · 6 days agoQ4 2025

Next EarningsAug 13, 2026 · in 3 monthsBefore Market Open · Q2 2026

Financials

Based on Q4 2025 filing

Common questions about Cocrystal Pharma

Cocrystal Pharma (COCP) has a market capitalization of $15.9M and trades on NASDAQ.

Cocrystal Pharma has approximately 12 employees.